13-113115754-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_019616.4(F7):​c.459C>T​(p.His153His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,613,076 control chromosomes in the GnomAD database, including 14,626 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1330 hom., cov: 33)
Exomes 𝑓: 0.13 ( 13296 hom. )

Consequence

F7
NM_019616.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.13
Variant links:
Genes affected
F7 (HGNC:3544): (coagulation factor VII) This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 13-113115754-C-T is Benign according to our data. Variant chr13-113115754-C-T is described in ClinVar as [Benign]. Clinvar id is 255218.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113115754-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F7NM_019616.4 linkc.459C>T p.His153His synonymous_variant Exon 5 of 8 ENST00000346342.8 NP_062562.1 P08709-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F7ENST00000346342.8 linkc.459C>T p.His153His synonymous_variant Exon 5 of 8 1 NM_019616.4 ENSP00000329546.4 P08709-2

Frequencies

GnomAD3 genomes
AF:
0.127
AC:
19248
AN:
152142
Hom.:
1328
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.134
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.122
Gnomad ASJ
AF:
0.207
Gnomad EAS
AF:
0.0472
Gnomad SAS
AF:
0.276
Gnomad FIN
AF:
0.0765
Gnomad MID
AF:
0.207
Gnomad NFE
AF:
0.120
Gnomad OTH
AF:
0.144
GnomAD2 exomes
AF:
0.137
AC:
34334
AN:
250174
AF XY:
0.146
show subpopulations
Gnomad AFR exome
AF:
0.136
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.195
Gnomad EAS exome
AF:
0.0502
Gnomad FIN exome
AF:
0.0749
Gnomad NFE exome
AF:
0.126
Gnomad OTH exome
AF:
0.142
GnomAD4 exome
AF:
0.126
AC:
183916
AN:
1460816
Hom.:
13296
Cov.:
33
AF XY:
0.132
AC XY:
95567
AN XY:
726700
show subpopulations
Gnomad4 AFR exome
AF:
0.138
AC:
4627
AN:
33478
Gnomad4 AMR exome
AF:
0.118
AC:
5269
AN:
44712
Gnomad4 ASJ exome
AF:
0.195
AC:
5104
AN:
26136
Gnomad4 EAS exome
AF:
0.0580
AC:
2304
AN:
39700
Gnomad4 SAS exome
AF:
0.278
AC:
23941
AN:
86248
Gnomad4 FIN exome
AF:
0.0786
AC:
4125
AN:
52456
Gnomad4 NFE exome
AF:
0.116
AC:
129202
AN:
1111942
Gnomad4 Remaining exome
AF:
0.134
AC:
8070
AN:
60376
Heterozygous variant carriers
0
9524
19048
28573
38097
47621
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
4740
9480
14220
18960
23700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.126
AC:
19256
AN:
152260
Hom.:
1330
Cov.:
33
AF XY:
0.126
AC XY:
9374
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.134
AC:
0.134314
AN:
0.134314
Gnomad4 AMR
AF:
0.122
AC:
0.122304
AN:
0.122304
Gnomad4 ASJ
AF:
0.207
AC:
0.207373
AN:
0.207373
Gnomad4 EAS
AF:
0.0473
AC:
0.0472608
AN:
0.0472608
Gnomad4 SAS
AF:
0.276
AC:
0.276141
AN:
0.276141
Gnomad4 FIN
AF:
0.0765
AC:
0.0765094
AN:
0.0765094
Gnomad4 NFE
AF:
0.120
AC:
0.120222
AN:
0.120222
Gnomad4 OTH
AF:
0.143
AC:
0.142857
AN:
0.142857
Heterozygous variant carriers
0
888
1777
2665
3554
4442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.128
Hom.:
2567
Bravo
AF:
0.129
Asia WGS
AF:
0.159
AC:
552
AN:
3478
EpiCase
AF:
0.136
EpiControl
AF:
0.137

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Nov 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Factor VII deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.3
DANN
Benign
0.63
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6042; hg19: chr13-113770068; COSMIC: COSV60645205; COSMIC: COSV60645205; API